What is the prognosis for patients with subarachnoid hemorrhage?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Prognosis of Subarachnoid Hemorrhage

Subarachnoid hemorrhage carries a 19% mortality rate at 3 months, with approximately 40% of treated patients achieving favorable outcomes, though prognosis varies dramatically based on initial clinical grade, age, and development of complications. 1

Overall Mortality and Morbidity

The prognosis for aneurysmal subarachnoid hemorrhage (aSAH) remains sobering despite advances in neurocritical care. At 3-month follow-up, the mortality rate is 19%, with deaths distributed equally among four major causes: direct effects of initial hemorrhage (19%), rebleeding (22%), vasospasm (23%), and medical complications (23%). 2 This underscores that aSAH is not merely a neurosurgical problem but a systemic disease requiring comprehensive critical care management.

Clinical Grading as Prognostic Indicator

Use of clinical grading scales (Hunt and Hess or World Federation of Neurosurgical Societies grades) is essential for determining initial severity and predicting outcome (Class I recommendation, Level B-NR evidence). 1 These scales provide standardized prognostic information:

  • High-grade SAH (Hunt and Hess 4-5 or WFNS 4-5): Approximately 40% achieve favorable outcomes at 12 months when treated 1
  • Low-grade SAH: Substantially better prognosis, though not without risk

The most important prognostic factors in descending order are: cerebral infarction, neurological grade, age, fever on day 8, intraventricular hemorrhage, vasospasm, amount of subarachnoid blood, intracerebral hematoma, and history of hypertension. 3

Age-Related Outcomes

Age profoundly impacts prognosis as a continuous variable, with particularly increased risk after age 60. 4 However, older patients should not be automatically excluded from treatment:

  • Patients >65 years: 42% achieve functional independence at 6-year follow-up 1
  • Patients <65 years: 82% achieve functional independence at 6-year follow-up 1

The aging brain demonstrates less optimal response to initial bleeding, and this effect persists even after adjusting for other prognostic factors. 4 Older patients present with worse consciousness levels, more intraventricular hemorrhage, higher rebleeding rates (16.4% vs 4.5% in younger patients), and more severe medical complications. 4

Delayed Cerebral Ischemia and Vasospasm

Symptomatic vasospasm occurs in 46% of patients and represents a major modifiable prognostic factor. 2 Delayed cerebral ischemia (DCI) results from multiple mechanisms beyond large-vessel vasospasm, including arteriolar constriction, microthrombosis, cortical spreading depolarization, blood-brain barrier breakdown, and impaired cerebral autoregulation. 1

Cerebral infarction contributes most to outcome variation among all prognostic factors. 3 This emphasizes the critical importance of DCI prevention and management in the acute phase.

Long-Term Functional Outcomes

Among survivors achieving good neurological outcomes, 94% attain functional independence (mRS ≤1), but substantial quality-of-life deficits persist. 1, 5 At 4-7 years post-SAH:

  • Memory problems: 41% of survivors 6
  • Changed personality: 48% 6
  • Daytime sleepiness: 35% 6
  • Reduced work capacity: 20% 6
  • Headaches: 16.5% 6

Cognitive recovery continues for years, and most survivors develop good coping skills despite ongoing problems. 6 Patients without neurological deficit at discharge typically return to normal cognitive function by 3 months and should be encouraged to resume normal lifestyle. 5

Medical Complications

Forty percent of patients experience at least one life-threatening medical complication, with pulmonary complications being the most common cause of non-neurologic death. 2 Key complications include:

  • Pulmonary edema: 23% (6% severe), with peak incidence days 3-7 2
  • Cardiac arrhythmias: 30% (5% life-threatening), increased on day of or after surgery 2
  • Hepatic dysfunction: 24% (4% severe) 2
  • Renal dysfunction: 7% 2

Critical Pitfalls

The most common prognostic error is nihilism regarding high-grade SAH. Patients with high-grade aSAH should be considered for aneurysm treatment unless they have irrecoverable and devastating neurological injury. 1 The 40% favorable outcome rate in this population justifies aggressive treatment with shared decision-making involving families.

Early aneurysm repair (within 24-72 hours) and management in specialized neurological ICUs with multidisciplinary teams has substantially improved outcomes. 1 Most prognostic factors present on admission are not modifiable, but substantial outcome contribution comes from factors developing after admission—particularly prevention of cerebral infarction, fever control, and management of medical complications. 3

References

5
Research

Recovery after subarachnoid haemorrhage.

BMJ (Clinical research ed.), 1989

Related Questions

In a 55-year-old woman with a sudden, worst-of-her-life headache of three-hour duration, neck pain, and a normal physical examination, what is the appropriate initial diagnostic test?
In a 27-year-old man with subarachnoid hemorrhage after a motor vehicle crash who has been intubated and now presents with severe hypoxemia, bradycardia, and is pulseless, what is the safest and most immediate method to verify correct endotracheal tube placement?
Are there any flight restrictions after a subarachnoid (subarachnoid space) hemorrhage (SAH)?
For an 80-year-old patient with acute intracranial hemorrhage and severe agitation, is it appropriate to prescribe intramuscular olanzapine (Zyprexa) 5 mg or intramuscular haloperidol (Haldol) 5 mg?
In a 61-year-old patient with Hunt-Hess grade 4, Fisher grade 4 subarachnoid hemorrhage, hypertension and congestive heart failure, and a small blister aneurysm arising from a distal basilar artery perforator, what are the management and treatment options?
What is the appropriate emergency evaluation and management for a 2‑year‑old child who has ingested amlodipine (a calcium‑channel blocker) and an unknown substance referred to as “Corey”?
In a child with a urine pH of 8, what are the likely crystal types and what management steps should be taken?
What traumatic injury can cause a patient to develop both hemorrhagic (hypovolemic) shock and neurogenic shock?
How often should chest X‑ray be repeated for a patient with a small pleural effusion that is unchanged on the prior X‑ray?
What are the recommendations for discontinuing levetiracetam (Keppra) after seizures following an embolic stroke during bypass surgery?
What organisms does Bactroban (mupirocin) cover?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.